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ABSTRACT 26 
PCR fingerprinting was used to type 177 yeast isolates obtained from two Medical 27 
Institutions. Candida albicans was the predominant species found followed by C. tropicalis, 28 
C. glabrata, C. parapsilosis, C. guilliermondii and C. krusei which accounted for over 20% of 29 
the strains isolated. This survey represents the first study of molecular epidemiology of 30 
candidiasis in Portugal. 31 
 32 
In the last decade yeasts belonging to the genus Candida have emerged as major opportunistic 33 
pathogens mainly due to the increase of immunocompromised patients (19, 26, 2, 5). 34 
Although C. albicans is the most frequent species isolated, other species such as C. tropicalis, 35 
C. guilliermondii, C. krusei, C. parapsilosis and C. glabrata have increasingly been 36 
recognized as pathogens with a wide distribution (6, 4). The significant increase in the 37 
frequency of candidiasis has promoted the study and development of a variety of molecular 38 
based techniques aiming at the replacement of the traditional methods used for the 39 
identification and typing of Candida clinical isolates. Among the current molecular 40 
techniques for genotyping of yeast strains, PCR fingerprinting is in wide use for its high 41 
discriminatory power and reproducibility also because it requires very little starting material 42 
and is rapid and simple to perform. PCR fingerprinting using the primer named T3B was 43 
developed firstly for Streptococcus identification (14), but it has been used successfully in the 44 
identification of yeast species belonging to the genus Candida (25, 1). 45 
The aim of the present work was to study the diversity and distribution of Candida species 46 
among patients suffering from different pathologies in two medical institutions located in 47 
Braga, north of Portugal. Approximately two hundred Candida clinical isolates were analysed 48 
using a PCR based methodology with primer T3B, representing the first study of molecular 49 
epidemiology of candidiasis in this country. 50 
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Yeast clinical isolates were obtained from 123 independent patients during the year of 2001 in 51 
a Hospital and a Health Center. The yeast strains from the Hospital had been previously 52 
isolated at the institution of origin and collected from different body locations. The isolates 53 
from the Health Centre were all collected from vaginal exudates and isolated at the 54 
Microbiology Laboratory, University of Minho. The type cultures Candida albicans PYCC 55 
3436 (ATCC 18804), C. parapsilosis CBS 604 (ATCC 22019), C. krusei PYCC 3343 (ATCC 56 
6258), C. tropicalis PYCC 3097 (ATCC 750), C. guilliermondii PYCC 2730 (ATCC 6260), 57 
C. lusitaniae PYCC 2705 (ATCC 34449), C. glabrata CBS 138 (ATCC 2001), C. 58 
dubliniensis CBS 7987 (ATCC MYA-646), and C. dubliniensis CBS 7988 were used as 59 
reference strains and supplied by the Portuguese Yeast Culture Collection (PYCC), New 60 
University of Lisbon, Portugal, except the isolates of C. parapsilosis, C. dubliniensis and C. 61 
glabrata that were obtained from Centraalbureau voor Schimmelcultures (CBS), The 62 
Netherlands. DNA extraction followed procedures previously described (7) and the 63 
oligonucleotide used as a single primer for arbitrary amplification was T3B (5'-AGG TCG 64 
CGG GTT CGA ATC C-3'). Amplification reactions were performed according to Thanos et 65 
al (25) without the condensing step of the amplification products. The D1/D2 domain of 26S 66 
rDNA was amplified according to the procedures described by Sampaio et al (21). 67 
Sequencing was performed with a ABI 310 Genetic Analyzer (Applied Biosystems Inc., 68 
Foster City, Calif.) using standard protocols. Forward and reverse sequence alignments were 69 
made with MegAlign (DNAStar, Inc. Park Street, Madison, USA) and visually corrected. 70 
PCR fingerprinting profiles were analysed using the Bionumerics (version 2.0, Applied Maths 71 
BVBA, Sint-Martens-Latem, Belgium). Similarity coefficients were calculated using the Dice 72 
algorithm and cluster analysis performed by means of the unweighted paired group method 73 
using arithmetic averages (UPGMA) (23).  74 
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A preliminary characterisation of the 177 yeast strains isolated using a rapid identification kit 75 
indicated that they all belonged to the genus Candida although several doubts arose regarding 76 
species identity. PCR fingerprinting profiles were obtained, with primer T3B, for the type 77 
strains of C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. guilliermondii, C. krusei 78 
and C. lusitaniae, the most common species found among yeast clinical isolates. Results 79 
showed that the different species tested could be clearly distinguished by their amplification 80 
patterns since the number and size of the amplification products were characteristic for each 81 
species (Fig. 1). 82 
By comparing the PCR profiles of the clinical isolates with those of the reference type strains, 83 
all clinical isolates could be identified to the species level, except in the case of four of the 84 
strains which did not produce recognisable patterns. Three of them (36M, 65M and 66M) 85 
shared identical profiles while 153M presented a different but unique fingerprint. These 86 
strains had been preliminarily identified as C. parapsilosis and C. glabrata, respectively (Fig. 87 
2). Although intraspecies variability was observed, PCR profiles obtained from different 88 
strains assigned to the same species were far more similar than those derived from different 89 
species. Variability was found for isolates of C. albicans, C. tropicalis, C. guilliermondii, and 90 
C. parapsilosis, being C. albicans the species that exhibited greater diversity. On the opposite, 91 
no variability was observed in the profiles obtained for both C. glabrata and C. krusei 92 
isolates. Our results agree with those of Thanos et al (25) who used the same methodology to 93 
differentiate Candida species. These authors used a condensing step of the amplification 94 
products before electrophoresis which was not performed in this study and, consequently, 95 
variability within a species might have been reduced. However, as our goal was the 96 
identification at species level, the methodology with this missing step turned out to be less 97 
time consuming and produced easily recognisable profiles maintaining high species 98 
discrimination. The high power of discrimination of PCR fingerprinting using primer T3B 99 
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allowed the identification of over 98% of the 177 clinical isolates and the detection of 100 
misidentifications made by API 32C.  101 
To investigate the presence of C. dubliniensis the T3B profiles of two strains, including the 102 
type strain, were obtained and compared with the ones found for C. albicans. T3B 103 
fingerprinting clearly distinguished these closely related species since no similarities were 104 
observed between the amplification patterns of the two species (Fig. 3). No isolates of C. 105 
dubliniensis were found which is not surprising since this yeast species is commonly reported 106 
from oral candidiasis, mainly among human immunodeficiency virus-infected individuals 107 
(24), not included in this study. Previous reports also refer the differentiation of these two 108 
species by PCR fingerprinting (16) but this was the first time that T3B fingerprints have been 109 
applied for this purpose. 110 
To evaluate the taxonomic resolution of T3B amplification profiles cluster analysis was 111 
applied to the data and the dendrogram presented in Figure 4 was produced showing a very 112 
high correspondence between the clusters and the different Candida species. The calculated 113 
cophenetic correlation coefficient (0.97) indicated that the fit for the cluster analysis was very 114 
good. This analysis allowed the distribution of the isolates in seven major clusters 115 
corresponding to the species studied. The four isolates that did not produce recognizable T3B 116 
patterns grouped separately and the strains that were originally misidentified grouped within 117 
the clusters corresponding to their respective T3B profile.  118 
The four strains displaying peculiar banding profiles were further investigated by sequencing 119 
the D1/D2 domain of their 26S rDNA. Sequencing results for strains 36M, 65M and 66M 120 
(GenBank accession no. AY589574) showed a 100% similarity between them and with strain 121 
Candida sp. NRRL Y-17456, which appears to be highly related to C. parapsilosis but has 122 
been referred as a new species (9, 13). Furthermore, their T3B profiles did not match with the 123 
ones of the other C. parapsilosis strains (Fig. 2). This species remains a source of controversy 124 
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since three genetically distinct subtypes (I, II and III) were defined (10, 12, 11, 20) presenting 125 
variability enough to justify separate species status for the three subgroups. Strain 153M 126 
(GenBank accession no. AY589572) formerly identified as C. glabrata also presented 127 
differences when compared with sequences available for C. glabrata (94% similarity). 128 
Despite seeming to be related to C. glabrata no conclusive identification was obtained for this 129 
strain which is, most probably, a new species based on the high number of nucleotide 130 
substitutions observed (9, 18).  131 
Of the 177 Candida strains 112 isolates were obtained from vaginal swabs, 24 from urine, 23 132 
isolated from the upper respiratory system, seven from the anal mucosa and 11 isolates from 133 
various sources. The number of strains belonging to each of the species found and their 134 
respective clinical origin is shown in Table 1. C. albicans was the predominant species 135 
(79.0%) followed by C. tropicalis (5.6%), C. glabrata (4.0%) and C. parapsilosis (3.4%) 136 
which is in accordance with several reports (6, 4, 8 3, 5). C. guilliermondii represented 2.8%, 137 
C. krusei 2.3%, C. lusitaniae 0.6% and the isolates whose identification was not conclusive, 138 
Candida sp., represented 2.3% of the total. C. albicans was present in all types of clinical 139 
material except in blood samples and C. tropicalis was mainly recovered from the urine and 140 
respiratory tract. While C. albicans was predominant among vaginal isolates the non-albicans 141 
species were recovered mainly from other sources. Little is known about the epidemiology of 142 
candidiasis in Portugal (17, 15, 22). Our study despite covering a small area and only two 143 
medical institutions is a representative survey since patients with different pathologies were 144 
included. We show that over 20% of the infections are due to non albicans species which may 145 
not respond to antifungal agents usually used in treatment requiring more adequate means of 146 
therapy. Therefore it is of the utmost importance to identify the species causing infection and 147 
this PCR based methodology is simple and can be implemented at relatively low cost for 148 
routine identification in hospitals and health centres. This method is more accurate in 149 
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identifying species of the genus Candida than any biochemical approach currently used in 150 
Clinical Microbiology laboratories and, consequently, better suited for large epidemiological 151 
surveys. 152 
 153 
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Fig. 1. PCR profiles obtained with primer T3B for: Candida glabrata CBS 138 (1); C. 235 
parapsilosis CBS 604 (2); C. tropicalis PYCC 3097 (3); C. krusei PYCC 3440 (4); C. 236 
guilliermondii PYCC 2730 (5); C. lusitaniae PYCC 2705 (6); C. albicans PYCC 3436 (7); 237 
molecular weight marker in bp (M). 238 
 239 
Fig. 2. PCR profiles obtained with primer T3B for C. parapsilosis (lanes 1-2); strain 36M (3); 240 
strain 65M (4); strain 66M (5); strain 153M (6); C. glabrata (lanes 7-10); molecular weight 241 
marker in bp (M). 242 
 243 
Fig. 3. PCR profiles obtained with primer T3B for C. albicans (lanes 1, 2) and C. dubliniensis 244 
(Lanes 2, 3).  245 
 246 
Fig. 4. Dendrogram showing the degree of similarity of T3B fingerprinting profiles among 247 
the clinical Candida isolates using the Dice coefficient and UPGMA cluster method. The 248 
unidentified strains are indicated as follows: * 36M, 65M and 66M; ** 153M. An arbitrary 249 
line has been drawn at 0.58 delimitating the major groups. r-cophenetic correlation 250 
coefficient. 251 
 252 
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 260 
TABLE 1. Yeast species identified, number of strains of each species, and respective 261 
sources of isolation 262 
 263 
 
Species 
 
Number of strains 
 
Body site 
 
C. albicans 
 
19 
 
Urine 
 
 
 
 
 
 
 
C. tropicalis 
16 
2 
95 
6 
1 
1 
 
4 
3 
1 
1 
1 
Respiratory tract 
Peritoneal fluid 
Vagina 
Anal mucosa 
Cateter 
Unknown 
 
Urine 
Respiratory tract 
Pus 
Blood 
Vagina 
C. parapsilosis 4 
1 
1 
Vagina 
Blood 
Unknown 
 
 
C. guilliermondii 
 
4 
1 
 
Vagina 
Blood 
 
C. glabrata 
 
5 
1 
1 
 
Vagina 
Urine 
Anal mucosa 
 
C krusei 
 
 
1 
1 
2 
 
Blood 
Unknown 
Vagina 
 
C. lusitaniae 
 
1 
 
Respiratory tract 
 
Candida sp. 3 
1 
Respiratory tract 
Vagina 
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